TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DRIEX

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

DRIEX

ST13

US500000079302001

Classe

10, 20

Pedido

79302001

Registro

6696055

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

20/09/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

10, 20

Data de depósito

26/11/2020

Data de registro

12/04/2022

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

12/04/2022

Última transação

12/04/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

35

Localização do titular

IT

Examinador

HARMON, RAYMOND E

Unidade examinadora

L30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

BORMIOLI PHARMA S.p.A.

Representantes

Zachary A. Aria Blank Rome LLP

Classificação técnica

Classes Nice

Classe 10Classe 20

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 10

Flasks for parenteral nutrition, namely, container and drug reconstitution system for injections and infusions, all being medical apparatus in the nature of infusion and injection devices for administering drugs; drug delivery devices sold empty, namely, flasks for medical use; dropper bottles for administering medication, sold empty, for medical purposes; vaporizers for medical purposes; suction bottles for medical use, namely, feeding bottles, nursing bottles, and dropper bottles for administering medication, sold empty; dropper bottles for administering medication, sold empty; syringes for medical purposes; syringes for injections; haemoperfusion cartridges being structural part of dialysis machines and blood containers for medical purposes; feeding bottles; droppers for administering medication, sold empty, for medical purposes; droppers for administering medication, sold empty; medical trays for holding surgical instruments; measuring spoons for administering medicine; spoons for administering medicine; non-spill medicine spoons for infants; intravenous feeding bottles; medicinal bottle stoppers, namely, bottle stoppers specifically adapted for feeding bottles and baby bottles; breast milk storage bottles; medical tubing for administering drugs; injection device for pharmaceuticals; dropping pipettes for medical purposes; containers made of glass or plastic for pharmaceutical or parapharmaceutical or medical use, namely, bottles for injectable substances, bottles for medicines, bottles for reagents, bottles for infusions, bottles for aerosols, vials, ampoules, cartridges, syringes, and pill bottles; diagnostic devices, namely, sample preparation device for medical diagnostic use, blood pressure and diabetic diagnostic medical devices, and diagnostic kit consisting primarily of probes, buffers and reagents for use in microbial testing used in laboratories for Point of Care Testing (POCT) for integrated electronic systems for the administration of medical substances; cartridges of plastic for diagnostic purposes, namely, replacement and structural components of medical diagnostic apparatus for detecting diseases, integrated electronic system for the administration of medical substances being delivery systems and medical instruments for measuring and displaying blood pressure and lung capacity; consumable laboratory cartridges for diagnostic use in laboratories, namely, replacement and structural components of medical diagnostic apparatus for detecting diseases, integrated electronic system for the administration of medical substances being drug delivery systems and medical instruments for measuring and displaying blood pressure and lung capacity; valves and accessories for intravenous drug administration of medicinal products, namely, subcutaneous valves comprised of artificial material for implantation, feeding bottle valves, intravenous bags sold empty for intravenous therapy, intravenous feeding tubes, replacement and structural parts of injection devices for administering drugs in the nature of stoppers, connectors and IV extensions and IV cannulas, and stopcocks; medical diagnostic apparatus for sale in kit form for medical diagnostic purposes, namely, diagnostic kits consisting primarily of probes, buffers, and reagents for use in microbial testing; clinical-medical test kits for clinical medical use containing test tubes, test plates and indicator charts for evaluating test results; containers for medical reagents, namely, containers specially designed for transporting and holding radiopharmaceuticals; integrated electronic systems for administering medical substances comprised primarily of medical apparatus for intravenous administration of fluids in the nature of fluid warmers, spoons for administering medicine, intravenous feeding tubes and also containing computer hardware and software for administering medical substances; integrated electronic systems for the registration of medical data comprised primarily of medical devices used for the acquisition of physiological data for polysomnography, medical instruments for measuring and displaying medical data in the nature of blood pressures and lung capacity and also containing computer hardware and software for registering medical data; integrated electronic systems for the registration of pharmaceutical data comprised primarily of medical apparatus for introduction pharmaceutical preparations into the human body, medical instruments for measuring and displaying medical data in the nature of blood pressures and lung capacity, injection devices for pharmaceuticals and also containing computer hardware and software for registering pharmaceutical data; medical prostheses for breast, hand and implants consisting of artificial materials for surgical purposes; sterile containers to be filled with medical products, namely, containers for medical waste, blood containers for medical purposes sold empty; sterile containers for surgical purposes, namely, containers for medical waste, blood containers for medical purposes sold empty; cartridges of plastic for containing and administering medical products for diagnostic use in laboratories for Point of Care Testing (POCT), namely, medical apparatus in the nature of infusion and injection devices for administering drugs; cartridges of glass for containing and administering medical products for diagnostic use in laboratories for Point of Care Testing (POCT), namely, medical apparatus in the nature of infusion and injection devices for administering drugs; cartridges of plastic for containing and administering reagents as parts of ultrasonic medical diagnostic apparatus; cartridges of glass for containing and administering reagents as parts of ultrasonic medical diagnostic apparatus; needles of metal for parenteral administration; drug recovery accessories, namely, drug delivery systems

Classe 20

Container closures of plastic; plastic medication containers for commercial use; containers, not of metal, for commercial use; bottle closures, not of metal; closures for containers, non-metallic; corks for bottles; plastic stoppers for bottles; screwcaps and caps of plastic for the closure of containers; sealing caps, not of metal; closures of plastics for containers for detecting tampering, namely, locking plastic cap that covers bung openings in plastic and metal containers for tamper evidence

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

20/09/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

26/08/2022

FIMP

FINAL DISPOSITION PROCESSED

25/08/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/07/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/04/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/01/2022

PUBO

PUBLISHED FOR OPPOSITION

25/01/2022

GPNX

NOTIFICATION PROCESSED BY IB

22/01/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/01/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/01/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/01/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

20/12/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

20/12/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

20/12/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

20/12/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

20/12/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

16/11/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/11/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

16/11/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

16/11/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

16/11/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

16/11/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

16/11/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

16/11/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

16/11/2021

RFNT

REFUSAL PROCESSED BY IB

07/06/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

19/05/2021

RFRR

REFUSAL PROCESSED BY MPU

19/05/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

19/05/2021

CNRT

NON-FINAL ACTION WRITTEN

18/05/2021

DOCK

ASSIGNED TO EXAMINER

12/05/2021

MAFR

APPLICATION FILING RECEIPT MAILED

15/01/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/01/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/01/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DRIEX ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.